Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence

.blurhash-client-img { display: none !important; }

Open Access

|Feb 2016

Authors

Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Department of Pathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Department of Hematology and Oncology, University Children’s Hospital, Ljubljana, Slovenia

DOI: https://doi.org/10.1515/raon-2015-0026 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Language: English

Page range: 80 - 86

Submitted on: Feb 2, 2015

Accepted on: Feb 23, 2015

Published on: Feb 16, 2016

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2016 Ana Lina Vodusek, Katja Goricar, Barbara Gazic, Vita Dolzan, Janez Jazbec, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.